Literature DB >> 12607778

Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography.

Dushyant Sahani1, Srinivasa Prasad, Sanjay Saini, Peter Mueller.   

Abstract

CT provides limited assistance in the differentiation between serous and mucinous neoplasms. Because of the variability in the radiographic appearance of serous cystadenomas and overlap in CT characteristics with mucinous neoplasms, most serous neoplasms still require ancillary testing such as biopsy to reach a definitive diagnosis. MRCP is useful in differentiating benign and malignant mucinous tumors including IPMT of the pancreas. The presence of mural nodules is suggestive of malignancy; however, the absence of mural nodules does not indicate that the tumor is benign. A maximum main pancreatic duct diameter of greater than 15 mm and diffuse dilatation of the main pancreatic duct are suggestive of malignancy in main duct-type tumors. Among branch duct-type tumors, malignant tumors tend to be larger than benign tumors; however, this finding is variable. The presence of main pancreatic duct dilatation may be helpful in determining malignancy of branch duct-type tumors.

Entities:  

Mesh:

Year:  2002        PMID: 12607778     DOI: 10.1016/s1052-5157(02)00022-3

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  16 in total

1.  Incidentally discovered benign pancreatic cystic neoplasms not communicating with the ductal system: MR/MRCP imaging appearance and evolution.

Authors:  R Manfredi; M Bonatti; M D'Onofrio; S Mehrabi; R Salvia; W Mantovani; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

Review 2.  [Importance of endoscopy and endosonography for chronic pancreatitis and benign pancreas tumors].

Authors:  M Fuchs; W Schepp
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

3.  Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol.

Authors:  Stephanie Nougaret; Caroline Reinhold; Jaron Chong; Laure Escal; Gregoire Mercier; Jean Michel Fabre; Boris Guiu; Nicolas Molinari
Journal:  Eur Radiol       Date:  2014-02-26       Impact factor: 5.315

Review 4.  Management of mucinous cystic neoplasms of the pancreas.

Authors:  Mario Testini; Angela Gurrado; Germana Lissidini; Pietro Venezia; Luigi Greco; Giuseppe Piccinni
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

5.  Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment.

Authors:  Jennifer F Tseng; Andrew L Warshaw; Dushyant V Sahani; Gregory Y Lauwers; David W Rattner; Carlos Fernandez-del Castillo
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

6.  F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.

Authors:  Cosimo Sperti; Claudio Pasquali; Giandomenico Decet; Franca Chierichetti; Guido Liessi; Sergio Pedrazzoli
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

Review 7.  Management of serous cystadenoma of the pancreas.

Authors:  Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2007-10-25       Impact factor: 3.452

Review 8.  Cystic neoplasms of the pancreas: a diagnostic challenge.

Authors:  Grant F Hutchins; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 9.  Pleomorphic giant cell carcinoma of the pancreas with hepatic metastases--initially presenting as a benign serous cystadenoma: a case report and review of the literature.

Authors:  Petrou Athanasios; Papalambros Alexandros; Brennan Nicholas; Karles Dimitrios; Bramis Kostantinos; Manzelli Antonio; Papalambros Efstathios
Journal:  HPB Surg       Date:  2010-12-20

10.  MDCT evaluation of the growth kinetics of serous and benign mucinous cystic neoplasms of the pancreas.

Authors:  Hamid Chalian; Hüseyin G Töre; Pedram Rezai; David J Bentrem; Vahid Yaghmai
Journal:  Cancer Imaging       Date:  2011-08-20       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.